Endpoint definition
↥| Name | G6_MYASTHENIA |
|---|---|
| Long name | Myasthenia gravis |
| Hospital Discharge registry | ICD-8: 7330 |
| Cause of Death registry | ICD-8: 7330 |
| KELA reimboursements codes | 108 |
| Level in the ICD-hierarchy | 3 |
| First defined in version | DF2 |
Myasthenia gravis
Myasthenia gravis: Myasthenia gravis (MG) is a rare, clinically heterogeneous, autoimmune disorder of the neuromuscular junction characterized by fatigable weakness of voluntary muscles.
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 232 | 133 | 99 |
| Unadjusted prevalence (%) | 0.11 | 0.11 | 0.11 |
| Mean age at first event (years) | 50.90 | 45.37 | 58.33 |
| Case fatality at 5-years (%) | 4.31 | 4.51 | 4.04 |
Longitudinal metrics
| All | Female | Male | |
|---|---|---|---|
| Median nb. of events per indiv. | 10.0 | 11.0 | 9.0 |
| Recurrence at 6 months (%) | 74.14 | 75.19 | 72.73 |
Survival analyses between endpoints
↥Plot
before Myasthenia gravis
after Myasthenia gravis
Loading survival analyses plot…
Table
Loading survival analyses table…